XORTX Therapeutics Cash from Financing (TTM) Analysis

XORTX Therapeutics Inc (XRTX)

2.61 -0.07 (-2.61%) USD | NASDAQ | May 10, 16:00

2.61 0.00 (0.00%) After-Hours: 19:06

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2015. Upgrade now.

Date	Value
December 31, 2023	-0.361M
September 30, 2023	5.156M
June 30, 2023	4.712M
March 31, 2023	4.715M
December 31, 2022	4.738M
September 30, 2022	13.26M
June 30, 2022	13.51M
March 31, 2022	13.60M
December 31, 2021	19.18M
September 30, 2021	4.302M
June 30, 2021	4.544M
March 31, 2021	4.528M
December 31, 2020	0.6708M
September 30, 2020	1.866M
June 30, 2020	1.83M
March 31, 2020	1.764M
December 31, 2019	0.0423M
September 30, 2019	-0.0759M
June 30, 2019	-0.0499M
March 31, 2019	-0.0766M

Date	Value
December 31, 2018	1.401M
September 30, 2018
June 30, 2018
March 31, 2018
December 31, 2017
November 30, 2017
September 30, 2017
August 31, 2017	0.0046M
May 31, 2017	0.2532M
March 31, 2017	0.2532M
February 28, 2017	0.2532M
November 30, 2016	0.2335M
August 31, 2016	0.1828M
May 31, 2016	0.1861M
February 29, 2016	0.1941M
November 30, 2015	0.2969M
August 31, 2015	0.0979M
May 31, 2015	0.0945M
February 28, 2015	0.1092M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-0.361M

Minimum

Dec 2023

19.18M

Maximum

Dec 2021

5.155M

Average

4.528M

Median

Mar 2021

Cash from Financing (TTM) Benchmarks